Beth Anlas
Internal Medicine · Riverview, FLNPI 1871723700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,565 and has fallen 87.8% since, to $191 in 2022.
Across 194 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$339
- Takeda Pharmaceuticals U.S.A., Inc.$305
- Gilead$293
- Amgen$289
- Pfizer$207
- AstraZeneca$168
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,253100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 22 | $339 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $305 |
| Gilead | 16 | $293 |
| Amgen(2 entities) | 21 | $289 |
| Pfizer | 12 | $207 |
| AstraZeneca | 10 | $168 |
| Amarin Pharma, Inc. | 9 | $153 |
| Johnson & Johnson | 7 | $125 |
| Biohaven Pharmaceuticals, Inc. | 5 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $100 |
| Merck | 5 | $98 |
| Novo Nordisk | 5 | $97 |
| Sanofi-aventis U.S. LLC | 5 | $96 |
| Eisai Inc. | 6 | $94 |
| Boehringer Ingelheim | 4 | $89 |
| GSK | 6 | $89 |
| Bausch Health US, LLC | 3 | $68 |
| Theratechnologies Inc. | 3 | $59 |
| Almatica Pharma LLC | 4 | $58 |
| Viiv Healthcare Company | 2 | $48 |
| Abbott | 2 | $47 |
| Bayer | 2 | $44 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| AbbVie(2 entities) | 2 | $37 |
| Genentech USA, Inc. | 2 | $32 |
| Clarus Therapeutics Inc. | 2 | $30 |
| Novartis | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| IBSA Pharma Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
How this compares
$3,253 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Riverview
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.